Neoadjuvant Nivolumab, Docetaxel, Cisplatin Therapy Followed by Surgery and Radiation Therapy for Resectable High Grade Salivary Gland Carcinoma
Condition(s):High-grade Salivary Gland CarcinomaLast Updated:February 14, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):High-grade Salivary Gland CarcinomaLast Updated:February 14, 2023Recruiting
Condition(s):Liver Cancer; Hepatocellular CancerLast Updated:April 13, 2017Terminated
Condition(s):Tumor; Breast CancerLast Updated:July 9, 2018Completed
Condition(s):Sintilimab, Cetuximab, Regorafenib,Combine,mCRCLast Updated:February 14, 2023Recruiting
Condition(s):Advanced Cutaneous Squamous Cell CarcinomaLast Updated:February 12, 2020Unknown status
Condition(s):Gastric Cancer; UnresectableLast Updated:November 30, 2020Completed
Condition(s):Non-Hodgkin LymphomaLast Updated:July 18, 2023Recruiting
Condition(s):Osteosarcoma; MetastasisLast Updated:April 23, 2018Completed
Condition(s):MelanomaLast Updated:February 16, 2021Withdrawn
Condition(s):Metastatic Colorectal CancerLast Updated:March 26, 2015Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.